Pathology of Hepatocellular Carcinoma and Tumor-Bearing Liver Tissue in Association with <i>hTERT</i> Promoter Mutation

<div>Survival of <i>hTERT</i>-wildtype (<i>hTERT</i>wt) and <i>hTERT</i>-promoter-mutated (<i>hTERT</i>mut) hepatocellular carcinoma (HCC), independent of the background liver tissue (a), and of <i>hTERT</i>wt and <i>hTERT</i>mut HCC in cirrhotic and noncirrhotic liver tissue. Based on age-matched Cox regression analysis (1 and 2), patients with <i>hTERT</i>mut HCC in cirrhotic and noncirrhotic liver tissue do not show a significant difference in overall survival at 3 years (b), 5 years (c), and 16 years (d).</div>

International Journal of Hepatology

fig2

Figure 2

Figure 2: Pathology of Hepatocellular Carcinoma and Tumor-Bearing Liver Tissue in Association with <i>hTERT</i> Promoter Mutation 

International Journal of Hepatology

Pathology of Hepatocellular Carcinoma and Tumor-Bearing Liver Tissue in Association with hTERT Promoter Mutation

Figure 2